Kadimastem Financial Statements From 2010 to 2024
| KDST Stock | ILA 1,189 14.00 1.19% |
Check Kadimastem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kadimastem's main balance sheet or income statement drivers, such as , as well as many indicators such as . Kadimastem financial statements analysis is a perfect complement when working with Kadimastem Valuation or Volatility modules.
Kadimastem |
Kadimastem Company Return On Asset Analysis
Kadimastem's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Kadimastem Return On Asset | -0.75 |
Most of Kadimastem's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kadimastem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Kadimastem has a Return On Asset of -0.7485. This is 91.45% lower than that of the Biotechnology sector and 96.83% lower than that of the Health Care industry. The return on asset for all Israel stocks is notably higher than that of the company.
Kadimastem Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kadimastem's current stock value. Our valuation model uses many indicators to compare Kadimastem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kadimastem competition to find correlations between indicators driving Kadimastem's intrinsic value. More Info.Kadimastem is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kadimastem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kadimastem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Kadimastem Financial Statements
Kadimastem stakeholders use historical fundamental indicators, such as Kadimastem's revenue or net income, to determine how well the company is positioned to perform in the future. Although Kadimastem investors may analyze each financial statement separately, they are all interrelated. For example, changes in Kadimastem's assets and liabilities are reflected in the revenues and expenses on Kadimastem's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Kadimastem. Please read more on our technical analysis and fundamental analysis pages.
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. The company was founded in 2008 and is based in Ness Ziona, Israel. KADIMASTEM operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 28 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kadimastem Stock
Kadimastem financial ratios help investors to determine whether Kadimastem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kadimastem with respect to the benefits of owning Kadimastem security.